Back to search

Institutes outside Greece

The role of the atypical chemokine receptor ACKR3 in bone marrow homeostasis

Abstract

dc:description

Daily hematopoietic cells are produced in the bone marrow (BM) in a process termed as hematopoiesis. At the apex of hematopoiesis, the hematopoietic stem cells (HSC) reside, the cells which produce all other hematopoietic cells (Haas et al., 2018). The chemokine CXCL12 and itsreceptor CXCR4 regulate hematopoiesis, retaining the HSC within the BM (Nagasawa et al., 1996, Ma et al., 1998). Additionally, CXCL12 binds to the atypical chemokine receptor ACKR3 (Burns et al., 2006). However, the expression and the role of ACKR3 within the BM remains undetermined, whereas the mechanism by which CXCL12 and CXCR4 maintain HSCs in the BM remains elusive. In this regard, the expression of ACKR3 was assessed using an ACKR3 reporter mouse line. In addition, the expression of the receptor was conditionally deleted in vivo and the effect in steady state and during emergency hematopoiesis, with the administration of the cytotoxic agent 5-Fluorouracil (5FU), was assessed. Furthermore, ACKR3 was pharmacologically inhibited and the role of the receptor in regulating CXCL12 was investigated. Finally, the role of the axis in HSC BM retention was evaluated in Ackr3-/-, Cxcl12-/- and Cxcr4-/- mice. The present study demonstrates that ACKR3 is not expressed in HSC and progenitor cells, but rather in the endosteal cells and in BM plasma cells. In addition, the conditional deletion of ACKR3 in all tissues, did not affect blood cell production, but induced HSCs to exit quiescence and acquire a proliferating phenotype. Similarly, conditional deletion of CXCL12 forced HSCs to exit dormancy, demonstrating that ACKR3 maintains HSC quiescence via CXCL12. The role of ACKR3 in HSC maintenance is even more pronounced during emergency hematopoiesis. In the absence of the receptor, mice exhibit enhanced mortality at day 10 after the administration of the cytotoxic agent. Under these conditions, ACKR3 also regulates Cxcl12 gene expression in aortic cells and hence, the concentration of CXCL12 in circulation. Nevertheless, ACKR3 deletion and the pharmacological inhibition of the receptor does not affect HSC mobilization. Deletion of CXCL12 and the artificial increase of circulating CXCL12 concentration further suggest that CXCL12 is not sufficient to regulate HSC retention and mobilization. On the contrary, the expression of CXCR4 on hematopoietic, but not on stromal cells, is essential for the maintenance of the cells in the BM. In conclusion, the present study unravels the differences in the expression pattern of CXCR4 and ACKR3 within the BM and reveals an unprecedented role for ACKR3 in the maintenance of HSC quiescence and the regulation of CXCL12 concentration under certain conditions. Finally, this study suggests that HSCs anchor in the BM via CXCR4, demonstrating that CXCR4 is the critical element for BM cell retention.

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Aslani, Maria
  • Ασλάνη, Μαρία

Subjects

dc:subject × 18

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60630

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Aslani, Maria; Ασλάνη, Μαρία. The role of the atypical chemokine receptor ACKR3 in bone marrow homeostasis. Institutes outside Greece, 2022. http://hdl.handle.net/10442/hedi/60630